As c-Myc is overexpressed in a wide variety of cancer types, among which are the most prevalent and aggressive of all malignancies, studying c-Myc has revealed new characteristics and novel vulnerabilities of cancer cells from a metabolic point of view as well as the relation between metabolic reprogramming and oncogenic drivers. This evidence concerns the gene MYC and cancer.